Cheng Xiang Dai

Corporate Officer/Principal at CELLULAR BIOMEDICINE GROUP, INC.

Health Technology

Consumer Services

Profile

Cheng Xiang Dai currently works at AbelZeta Pharma, Inc., as General Manager-Stem Cell Business Unit.
Dr. Dai also formerly worked at Venturepharma, Inc., as Medical Director.
Dr. Dai received his graduate degree from Zhengzhou University.

Cheng Xiang Dai active positions

Companies	Position	Start
CELLULAR BIOMEDICINE GROUP, INC.	Corporate Officer/Principal	11/07/2013

All active positions of Cheng Xiang Dai

Former positions of Cheng Xiang Dai

Companies	Position	End
Venturepharma, Inc. Venturepharma, Inc. Pharmaceuticals: MajorHealth Technology Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.	Chief Tech/Sci/R&D Officer	-

See the detail of Cheng Xiang Dai's experience

Training of Cheng Xiang Dai

Zhengzhou University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cheng Xiang Dai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Venturepharma, Inc. Venturepharma, Inc. Pharmaceuticals: MajorHealth Technology Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.	Health Technology
AbelZeta Pharma, Inc. AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD.	Health Technology